DEARNE VALLEY GROUP PRACTICE — All Prescriptions & Medications — Page 4
Practice Code: Y00411 | ROTHERHAM, S63 0LU
Showing results 151-200 of 666
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Bumetanide | 336 | 13.1K | £1.3K | +23.3% ▲ |
| Ivabradine | 334 | 14.1K | £1.5K | +251.3% ▲ |
| Ropinirole hydrochloride | 334 | 14.0K | £7.3K | +214.4% ▲ |
| Phenoxymethylpenicillin (Penicillin V) | 333 | 30.6K | £1.2K | +8.7% ▲ |
| Perindopril erbumine | 329 | 9,860 | £788 | -38.0% ▼ |
| Canagliflozin | 325 | 9,624 | £12.0K | +126.4% ▲ |
| Rabeprazole sodium | 322 | 10.8K | £1.1K | +524.3% ▲ |
| Rivaroxaban | 320 | 9,554 | £6.0K | -47.7% ▼ |
| Azithromycin | 312 | 4,727 | £1.4K | +146.1% ▲ |
| Baclofen | 303 | 71.7K | £973 | +51.3% ▲ |
| Pizotifen malate | 301 | 12.5K | £599 | +265.2% ▲ |
| Dexamethasone | 300 | 1,550 | £967 | +74.5% ▲ |
| Theophylline | 294 | 16.0K | £8.1K | +251.6% ▲ |
| Cyclizine hydrochloride | 293 | 17.9K | £617 | +81.6% ▲ |
| Medroxyprogesterone acetate | 293 | 293 | £1.6K | +142.7% ▲ |
| Tadalafil | 293 | 3,690 | £720 | +72.3% ▲ |
| Fluticasone propionate (Nasal) | 293 | 463 | £2.9K | +101.3% ▲ |
| Calcipotriol | 293 | 19.4K | £10.6K | +72.1% ▲ |
| Olanzapine | 288 | 7,700 | £997 | -22.3% ▼ |
| Aripiprazole | 286 | 14.4K | £2.7K | +12.4% ▲ |
| Cyanocobalamin | 286 | 8,246 | £671 | -19.0% ▼ |
| 282 | 1,196 | £696 | +28.0% ▲ | |
| Methotrexate | 270 | 6,868 | £1.7K | -17.0% ▼ |
| Sacubitril/valsartan | 267 | 12.7K | £20.8K | +11.5% ▲ |
| Biphasic insulin aspart | 266 | 1,930 | £11.5K | +162.0% ▲ |
| Enalapril maleate | 264 | 10.1K | £402 | +46.9% ▲ |
| Dorzolamide | 264 | 3,560 | £1.9K | +217.7% ▲ |
| Insulin degludec | 261 | 1,350 | £18.0K | +137.5% ▲ |
| Azathioprine | 261 | 9,830 | £344 | +140.8% ▲ |
| Clobetasone butyrate | 256 | 12.0K | £2.8K | +25.4% ▲ |
| Testosterone | 253 | 25.3K | £10.5K | +231.6% ▲ |
| Diazepam | 243 | 8,824 | £187 | -51.2% ▼ |
| Insulin Lispro | 242 | 1,587 | £12.3K | +216.3% ▲ |
| Trimethoprim | 236 | 11.0K | £534 | +15.5% ▲ |
| Sulfasalazine | 230 | 27.7K | £5.6K | +76.7% ▲ |
| 228 | 124.2K | £1.8K | -13.6% ▼ | |
| Letrozole | 226 | 6,440 | £581 | +21.0% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 225 | 25.3K | £2.8K | -0.4% vs avg |
| Indacaterol/glycopyrronium | 222 | 6,710 | £6.9K | +391.6% ▲ |
| Quinine sulfate | 222 | 6,328 | £1.1K | -23.3% ▼ |
| Methylphenidate hydrochloride | 221 | 10.7K | £7.9K | -14.4% ▼ |
| Fenofibrate | 217 | 4,963 | £538 | +124.3% ▲ |
| Aciclovir | 216 | 10.2K | £540 | +45.2% ▲ |
| Tirzepatide | 215 | 224 | £21.1K | +10.7% ▲ |
| Progesterone | 213 | 13.7K | £2.6K | -49.1% ▼ |
| Hydroxychloroquine sulfate | 212 | 7,148 | £333 | +9.5% ▲ |
| Verapamil hydrochloride | 210 | 11.6K | £1.5K | +131.4% ▲ |
| Prochlorperazine maleate | 208 | 10.8K | £579 | +2.9% ▲ |
| Loratadine | 206 | 7,705 | £171 | -1.4% vs avg |
| Orlistat | 205 | 17.7K | £4.2K | +148.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.